The company manufactures specialized paper sacks and flexible laminate packaging materials used primarily for tea, food, and industrial products.
The company possesses a narrow moat based on its specialized manufacturing capabilities for the tea industry and long-standing customer relationships, corroborated by a healthy average ROCE of 22%. However, the lack of EPS growth despite revenue gains suggests limited pricing power against raw material volatility.
Management has focused on phased modernization of its Balasore plants and expanding flexible laminate capacity. While ROCE is strong, the EPS CAGR of -0.5% over the period indicates that reinvested capital has not yet translated into bottom-line growth for shareholders.
The investment failed because the company became a 'treadmill' business, where heavy capital expenditure on plant modernization and flexible laminate expansion failed to outpace rising operational costs. While revenue grew, the combination of surging contractual labor expenses and raw material volatility permanently compressed margins. The lack of pricing power meant the company absorbed inflation rather than passing it on, resulting in the negative EPS growth trend accelerating until the high ROCE figures reverted to the mean of a commodity packaging provider.
RichFakir rates B & A Packaging India Ltd's business quality as decent — 60/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, B & A Packaging India Ltd is trading about 7% above our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on B & A Packaging India Ltd is: Watch — wait for price. A decent business, but at a fair price against our estimate of fair value — one to keep on the watchlist for a better entry.
RichFakir's educational estimate of B & A Packaging India Ltd's fair value is about ₹183 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →